tiprankstipranks
Trending News
More News >
Flotek Industries, Inc. (FTK)
NYSE:FTK
US Market

Flotek (FTK) AI Stock Analysis

Compare
269 Followers

Top Page

FTK

Flotek

(NYSE:FTK)

Select Model
Select Model
Select Model
Neutral 63 (OpenAI - 5.2)
Rating:63Neutral
Price Target:
$17.50
▲(4.73% Upside)
The score is driven primarily by improved profitability and low leverage, supported by a strong earnings-call backdrop with raised guidance and rapid, high-margin Data Analytics growth. Offsetting these positives are weak TTM cash generation (negative operating and free cash flow) and mixed near-term technical momentum, while valuation appears mid-range without dividend support.
Positive Factors
High‑margin Data Analytics Growth
Rapid, high-margin growth in Data Analytics signals a structural shift toward recurring, service-based revenue. A 71% segment gross margin and compliance wins (GPA 2172) support durable profitability and differentiation, reducing cyclicality versus chemicals.
Sustained Profitability Improvement
Material margin expansion and restored net income demonstrate improved unit economics and operating leverage. Strong EBITDA growth and upward guidance imply management is converting revenue into lasting profit, supporting reinvestment in growth initiatives.
Conservative Leverage and Improved ROE
Very low leverage gives financial flexibility to fund Data Analytics expansion, absorb operational volatility, and pursue strategic investments without heavy interest burden, while a rising ROE indicates more efficient equity capital deployment.
Negative Factors
Negative Operating and Free Cash Flow
Persistent negative operating and free cash flow despite accounting profits is a structural concern; it constrains organic investment, increases financing needs, and can force dilution or higher leverage if cash conversion doesn't improve within upcoming quarters.
Chemistry Segment Underperformance and Customer Concentration
Flat chemistry revenues and a major customer falling short of commitments indicate revenue concentration and execution risk. Continued underperformance could limit cash generation and slow overall top-line resilience if data analytics growth doesn't offset chemistry volatility.
Historical Volatility and Past High Leverage
A history of leverage spikes and uneven revenue growth signals structural earnings and balance sheet volatility. Combined with current cash flow deficits, this raises the risk that episodic stress could recur, limiting ability to fund sustained expansion without external financing.

Flotek (FTK) vs. SPDR S&P 500 ETF (SPY)

Flotek Business Overview & Revenue Model

Company DescriptionFlotek Industries, Inc. operates as a technology-driven chemistry and data company that serves customers across industrial, commercial, and consumer markets in the United States, the United Arab Emirates, and internationally. It operates in two segments, Chemistry Technologies (CT) and Data Analytics (DA). The CT segment designs, develops, manufactures, packages, distributes, delivers, and markets green specialty chemicals that enhance the profitability of hydrocarbon producers and cleans surfaces in commercial and personal settings to help reduce the spread of bacteria, viruses, and germs. This segment primarily serves integrated oil and gas, oilfield services, independent oil and gas, national and state-owned oil, geothermal energy, solar energy, and alternative energy companies. The DA segment designs, develops, produces, sells, and supports equipment and services that create and provide valuable information on the composition and properties of energy customers' hydrocarbon fluids. This segment's data platforms combine the energy industry's field-deployable, inline optical analyzer with proprietary cloud visualization and analytics. It sells its products directly through a mix of in-house sales professionals, as well as contractual agency agreements. The company was incorporated in 1985 and is headquartered in Houston, Texas.
How the Company Makes MoneyFlotek generates revenue primarily through the sale of its specialty chemicals and related services to oil and gas companies. The company has a diversified revenue model that includes direct sales of its chemical products, which are used in various applications such as drilling fluids, completion fluids, and enhanced oil recovery. Additionally, Flotek earns income through service contracts that involve the application of its products in the field, thereby providing technical support and expertise. Strategic partnerships with major oil and gas operators further enhance their market reach and revenue potential, allowing for collaborative projects that can lead to increased sales of their chemical solutions. The company may also benefit from pricing strategies that reflect the demand for more environmentally friendly and efficient products, positioning themselves competitively within the energy sector.

Flotek Key Performance Indicators (KPIs)

Any
Any
Revenue by Segment
Revenue by Segment
Chart Insights
Data provided by:The Fly

Flotek Earnings Call Summary

Earnings Call Date:Nov 04, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Mar 17, 2026
Earnings Call Sentiment Positive
The earnings call highlighted strong growth in the Data Analytics segment, significant gross profit improvement, and compliance achievements. However, the Chemistry segment faced challenges with flat revenue and sales shortfalls with ProFrac. Overall, the positive performance in Data Analytics and strategic achievements outweigh the challenges in the Chemistry segment.
Q3-2025 Updates
Positive Updates
Record-Breaking Data Analytics Revenue
Data analytics revenue surged by 232% compared to Q3 2024, marking the strongest quarter ever for this segment. Service revenues in the Data Analytics segment increased by 625% year-over-year.
Significant Increase in Gross Profit
Gross profit climbed 95% year-over-year, with a gross profit margin rising to 32% in Q3 2025.
Positive Net Income and EBITDA Growth
Net income totaled $20.4 million, while adjusted EBITDA increased by 142% year-over-year and over 20% sequentially.
Compliance Achievement in Data Analytics
The XSPCT analyzer became the first optical spectrometer to comply with GPA 2172 standards, enhancing high-margin revenue potential in the Data Analytics segment.
International Revenue Growth
International sales totaled $10 million through the first 9 months of 2025, up 122% from the previous year.
Negative Updates
Chemistry Revenue Challenges
Total chemistry revenues were flat compared to Q3 2024, and there was a 24% decline in active frac fleets.
ProFrac Chemistry Sales Shortfall
ProFrac's chemistry purchases were below the contractual minimum, leading to a discussion on potential underachievement in chemistry sales.
Company Guidance
During Flotek Industries' Third Quarter 2025 Earnings Conference Call, the company provided several key metrics and guidance updates. Flotek reported a 13% increase in total revenue compared to the third quarter of 2024, driven by a 232% rise in data analytics revenue and a 43% increase in external chemistry revenue. Gross profit surged by 95% year-over-year, with the gross profit margin climbing to 32%. Net income was $20.4 million, and adjusted EBITDA increased by 142% compared to the previous year and over 20% sequentially. The company announced a 6% increase in total revenue guidance and a 3% rise in adjusted EBITDA guidance for 2025. Additionally, Flotek highlighted safety achievements, including 0 lost time incidents and maintaining over 3,500 days without OSHA recordables or lost time incidences. The company's Data Analytics segment saw service revenues increase by 625% in Q3 2025 compared to Q3 2024, with a gross profit margin of 71%. Flotek's PWRtek assets contributed significantly, with revenues expected to reach $27.4 million in 2026. Overall, Flotek emphasized its ongoing transformation into a data-driven business model.

Flotek Financial Statement Overview

Summary
Flotek shows strong profitability recovery and improved margins, with low leverage. However, significant cash flow challenges persist, which could impact future operations.
Income Statement
75
Positive
Flotek's income statement shows a positive trajectory with a notable improvement in gross profit margin from 21.06% in 2024 to 25.81% in TTM (Trailing-Twelve-Months). The net profit margin also increased significantly to 14.48% in TTM, indicating enhanced profitability. Revenue growth is modest at 2.94% in TTM, but the company has turned around from previous losses, showing strong EBIT and EBITDA margins of 10.24% and 12.13% respectively. However, the company experienced volatility in revenue growth in prior years, which could pose a risk.
Balance Sheet
65
Positive
The balance sheet reflects a stable financial position with a low debt-to-equity ratio of 0.068 in TTM, indicating low leverage. Return on equity improved to 13.62% in TTM, showcasing efficient use of equity to generate profits. However, the equity ratio is not explicitly provided, and past high leverage in 2022 remains a concern.
Cash Flow
40
Negative
Cash flow analysis reveals challenges, with negative operating cash flow and free cash flow in TTM. The free cash flow growth rate is significantly negative, and the operating cash flow to net income ratio is also negative, indicating cash flow issues despite profitability. The free cash flow to net income ratio is high at 2.96, suggesting reliance on non-operating cash flows.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue220.50M187.03M188.06M136.09M43.27M53.14M
Gross Profit56.34M39.39M24.26M-6.70M3.26M-28.67M
EBITDA25.30M13.13M28.45M-34.54M-29.48M-139.16M
Net Income31.93M10.50M24.71M-42.30M-30.53M-136.45M
Balance Sheet
Total Assets212.69M170.80M157.51M164.81M50.24M86.21M
Cash, Cash Equivalents and Short-Term Investments4.60M4.40M5.85M12.29M11.53M38.66M
Total Debt14.18M12.85M17.88M119.58M13.26M14.80M
Total Liabilities102.19M56.90M55.55M162.21M30.05M39.04M
Stockholders Equity110.50M113.90M101.96M2.60M20.19M47.17M
Cash Flow
Free Cash Flow-5.23M1.42M-12.38M-45.05M-25.88M-49.26M
Operating Cash Flow-2.09M3.36M-11.30M-44.63M-25.84M-47.84M
Investing Cash Flow-3.05M-1.82M-1.01M5.33M112.00K-17.70M
Financing Cash Flow4.77M-3.12M5.93M38.27M-372.00K3.73M

Flotek Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price16.71
Price Trends
50DMA
16.11
Positive
100DMA
15.22
Positive
200DMA
13.63
Positive
Market Momentum
MACD
0.18
Positive
RSI
48.03
Neutral
STOCH
12.93
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FTK, the sentiment is Neutral. The current price of 16.71 is below the 20-day moving average (MA) of 17.52, above the 50-day MA of 16.11, and above the 200-day MA of 13.63, indicating a neutral trend. The MACD of 0.18 indicates Positive momentum. The RSI at 48.03 is Neutral, neither overbought nor oversold. The STOCH value of 12.93 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for FTK.

Flotek Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
$429.86M23.127.15%0.63%9.53%15.48%
70
Neutral
$318.15M22.465.54%1.71%-5.47%2.24%
67
Neutral
$489.32M21.823.31%-11.02%
65
Neutral
$15.17B7.614.09%5.20%3.87%-62.32%
63
Neutral
$483.03M18.7129.09%23.56%242.78%
62
Neutral
$464.22M-4.42-31.11%-1.29%-123.25%
61
Neutral
$294.36M-30.79-7.48%-18.29%-43.05%
* Energy Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
FTK
Flotek
16.71
7.56
82.62%
FET
Forum Energy Tech
41.90
22.26
113.34%
NGS
Natural Gas Services Group
33.64
4.52
15.52%
OIS
Oil States International
8.18
2.47
43.26%
GEOS
Geospace Technologies
23.49
13.65
138.72%
RNGR
Ranger Energy Services
14.70
-2.75
-15.76%

Flotek Corporate Events

Business Operations and StrategyExecutive/Board Changes
Flotek Approves Equity Awards for Executives
Neutral
Nov 21, 2025

On November 19, 2025, Flotek Industries’ Board of Directors approved equity awards for CEO Dr. Ryan Ezell and CFO J. Bond Clement, consisting of restricted stock units (RSUs) and performance-based restricted stock units (PRSUs). These awards are part of the company’s long-term incentive plan, with vesting conditions tied to financial performance and shareholder returns relative to the Russell 2000 Index. This move aims to align executive compensation with company performance and shareholder interests, potentially impacting the company’s strategic focus and market positioning.

The most recent analyst rating on (FTK) stock is a Hold with a $14.50 price target. To see the full list of analyst forecasts on Flotek stock, see the FTK Stock Forecast page.

Executive/Board Changes
Flotek’s Senior VP Amy Blakeway Departs Role
Neutral
Nov 17, 2025

On November 13, 2025, Amy Blakeway departed from her role as Senior Vice President, General Counsel, and Corporate Secretary of Flotek Industries, Inc. Her departure is classified as a termination for convenience, and the company plans to provide severance benefits as outlined in her employment agreement, pending the execution of a release agreement.

The most recent analyst rating on (FTK) stock is a Buy with a $19.00 price target. To see the full list of analyst forecasts on Flotek stock, see the FTK Stock Forecast page.

Business Operations and StrategyFinancial Disclosures
Flotek Reports Strong Q3 2025 Financial Performance
Positive
Nov 4, 2025

On November 4, 2025, Flotek Industries announced a significant financial performance for the third quarter of 2025, with a 95% increase in gross profit and a 704% rise in net income compared to the same period in 2024. The company’s Data Analytics segment played a crucial role in this growth, contributing 16% to total revenues and achieving a gross profit margin of 71%. Flotek’s strong performance led to an upward revision of its 2025 financial guidance, reflecting confidence in continued growth and value creation for stakeholders.

The most recent analyst rating on (FTK) stock is a Buy with a $18.00 price target. To see the full list of analyst forecasts on Flotek stock, see the FTK Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 14, 2026